Skip to main content
NCBI home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2008 May 12;10(3):173–184. doi: 10.1111/j.1365-2990.1984.tb00350.x

SEQUENCE OF MURINE CORONAVIRUS JHM INDUCED NEUROPATHOLOGICAL CHANGES IN RATS

M KOGA 1,[Link], H WEGE 1, V TER MEULEN 1,✉
PMCID: PMC7168023  PMID: 6330603

Abstract

Infection of 21–25‐day‐old rats with the murine coronavirus JHM was followed either by an acute encephalomyelitis (AE) or subacute demyelinating encephalomyelitis (SDE). The major neuropathological finding in AE, which developed within 6–12 days pi. consisted of necrotizing lesions distributed mainly in the grey matter of the central nervous system (CNS). SDE developed 14–30 days pi. and affected rats revealed lesions of primary demyelination with predilection sites in the white matter. The time‐course for the development of lesions, virus replication and neutralizing antiviral antibody production within the first 3 weeks p.i. were studied. Within the first 2 weeks p.i., most rats showed no clinical signs but nevertheless revealed lesions typical of AE. In parallel to these neuropathological changes infectious virus could be isolated from brain and spinal cord. However, coinciding with multiplication of neutralizing JHM antibodies 10–12 days after infection no infectious virus was recoverable from CNS material. At this time many of the clinically healthy rats showed demyelinating lesions which were located at the typical predilection sites of SDE. These observations indicated that SDE was preceded by clinically silent AE lesions.

References

  1. Cheever F.S., Daniels J.B., Pappenheimer A.M. & Bailey O.T. (1949) A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin: I. Isolation and biological properties of the virus. Journal of Experimental Medicine 90, 181–194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Joseph B.S. & Oldstone M.B.A. (1975) Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation. Journal of Experimental Medicine 142, 864–876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Knobler R.L., Dubois‐Dalcq M., Haspel M.V., Claysmith A.P., Lampert P.W. & Oldstone M.B.A. (1981) Selective localization of wild type and mutant mouse hepatitis virus (JHM strain) antigens in CNS tissue by fluorescence, light and electron microscopy. Journal of Neuroimmunology 1, 81–92. [DOI] [PubMed] [Google Scholar]
  4. Knobler R.L., Lampert P.W. & Oldstone M.B.A. (1982) Virus persistence and recurring demyelination produced by a temperature‐sensitive mutant of MHV‐4. Nature 298, 279–280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lipton H.L. & Dal Canto M.C. (1976) Theiler's virus induced demyelination: prevention by immunosuppression. Science 192, 62–64. [DOI] [PubMed] [Google Scholar]
  6. Nagashima K., Wege H., Meyermann R. & Ter Meulen V. (1978) Corona virus induced subacute demyelinating encephalomyelitis in rats. A morphological analysis. Acta Neuropathologica 44, 63–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nagashima K., Wege H., Meyermann R. & Ter Meulen V. (1979) Demyelinating encephalomyelitis induced by a long‐term corona virus infection in rats. Acta Neuropathologica 45, 205–213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rima B.K. & Martin S.J. (1976) Persistent infection of tissue culture cells by RNA viruses. Medical Microbiology and Immunology 162, 89–118. [DOI] [PubMed] [Google Scholar]
  9. Sörensen O., Percy D. & Dales S. (1980) In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats. Archives of Neurology 37, 478–484. [DOI] [PubMed] [Google Scholar]
  10. Sörensen O., Dugre R., Percy D. & Dales S. (1982) In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice. Infection and Immunity 37, 1248–1260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sternberger L.A. & Petrali J.P. (1977) The unlabeled antibody enzyme method. Attempted use of peroxidase‐conjugated antigen as the third layer in the technique. Journal of Histochemistry and Cytochemistry 25, 1036–1042. [DOI] [PubMed] [Google Scholar]
  12. Stohlman S.A., Sakaguchi A.Y. & Weiner L.P. (1979) Characterization of the cold sensitive murine hepatitis virus mutants rescued from latently infected cells by cell fusion. Virology 98, 44–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ter Meulen V. & Hall W.W. (1978) Slow virus infections of the nervous system: virological, immunological and pathogenetic considerations. Journal of General Virology 41, 1–25. [DOI] [PubMed] [Google Scholar]
  14. Wege H., Stephenson J.R., Koga M., Wege H. & Ter Meulen V. (1981) Genetic variation of neurotropic and non neurotropic murine coronaviruses. Journal of General Virology 54, 67–74. [DOI] [PubMed] [Google Scholar]
  15. Wege H., Koga M., Watanabe R., Nagashima K. & Ter Meulen V. (1983) Neurovirulence of murine coronavirus JHM temperature sensitive mutants in rats. Infection and Immunity 39, 1316–1324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Weiner L. & Stohlman S.A. (1978) Viral models of demyelination. Neurology 28, 111–114. [DOI] [PubMed] [Google Scholar]

Articles from Neuropathology and Applied Neurobiology are provided here courtesy of Wiley

RESOURCES